# Latterell Venture Partners

Latterell Venture Partners is a Venture Capital based in San Ramon, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** San Ramon, United States
- **Region:** North America
- **Address:** San Ramon, CA, United States
- **Founded:** 2001
- **Assets under management:** $300M+
- **Website:** www.lvpcapital.com
- **LinkedIn:** https://linkedin.com/company/latterel-venture-partners

## Regulatory record

- **Reports private funds:** No

## About

Latterell Venture Partners invests in early-stage healthcare companies with innovative technologies and large market opportunities. The firm combines venture capital, entrepreneurial, technical, clinical, and collaborative skills to support entrepreneurs. Latterell Venture Partners has made 93 investments, including a Pre-Seed investment in Minit Games on March 02, 2026, and has 19 portfolio exits, with Viracta exiting on November 30, 2020.

## Sectors

- Healthcare Services
- Digital Health
- Medical Devices
- Biotechnology

## People

- Pat Latterell — Founder and Managing Director

## Questions

### Who runs investment decisions at Latterell Venture Partners?

Pat Latterell, the founder and managing director, leads investment decisions. His background in biomedical engineering and his tenure at Morgenthaler Ventures shaped the firm's focus on medical devices and tools. Day-to-day evaluation leverages a network of clinical advisors rather than a large partnership committee.

### What investment stages does Latterell Venture Partners typically target?

The firm concentrates almost entirely on early-stage opportunities — seed and Series A rounds where the science is solidifying around a specific clinical application. It avoids growth equity and late-stage biotech financings where large syndicates and crossover funds dominate. The model is designed for high ownership at company formation.

### Which sectors does Latterell Venture Partners explicitly avoid?

The firm does not invest in enterprise software, consumer internet, fintech, or generalist technology. Within healthcare, it has historically avoided small-molecule therapeutics and large Phase III biotech financings that require substantial capital reserves. Investments stay close to interventional medicine and tools.

### Does Latterell Venture Partners participate in fund commitments or only direct deals?

Latterell Venture Partners invests directly in portfolio companies and takes board seats where appropriate. It is not known to operate as a fund-of-funds or to allocate capital to outside GPs, keeping all investment activity inside its own fund vehicles.

### How does Latterell Venture Partners source proprietary deal flow?

The firm sources heavily through relationships with academic medical centers — Stanford, UCSF, and the Mayo Clinic are in its natural orbit — and through practicing surgeons who encounter unmet clinical needs. This clinical-advisor network surfaces opportunities before they reach broad institutional syndication.

### How is Latterell Venture Partners related to Morgenthaler Ventures?

Pat Latterell was a partner at Morgenthaler Ventures before founding Latterell Venture Partners. The firm carries forward the medical-device focus he built there, but Latterell Venture Partners is an entirely separate entity with its own funds and governance.

### What is Latterell Venture Partners' track record with exits?

Public record shows notable exits including Acclarent (acquired by Johnson & Johnson). The firm's early-stage device focus means exits historically come through strategic acquisition by large med-tech companies rather than IPOs.

## Related profiles

- [Latour Capital](https://altss.com/profile/latour-capital)
- [Lattice Capital Management](https://altss.com/profile/lattice-capital-management)

---

Last updated: 2026-07-08T23:28:43.146Z

Canonical page: https://altss.com/profile/latterell-venture-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology